Unbranded Immunology Strategy
Establishing Thought Leadership with Robust Medical Information and Educational Resources

Objective:
Drive education and awareness for immunology pathways and their mechanisms of action; differentiate the brand as an industry leader and trusted partner in advancing patient care through immunology research.
Strategy:
- Develop and optimize site establishing the role of TYK2 and other immunology pathways in disease management, preparing for a branded launch in 2026
- Generate media plan to drive engagement with key audiences nationwide
Content Hub / Persona Development / Thought Developement/ Engagement
Execution:
- Advance strategic refinements for site UX/UI Establish KPI benchmarks and measurement plan
- Develop robust US Engagement Strategy
Results:
- Increased educational awareness for the TYK2 pathway among healthcare professionals.
- Broadened awareness within the immunology community regarding pathways and current research.
- Notable increase in clinical trial involvement and sign-ups.
- Improved digital footprint and strategic positioning of BMS as a trusted industry leader.
- Enhanced user engagement metrics, including longer site visits and higher content interaction rates.